Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics OM

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Outset Medical Inc

OM
Current price
20.45 USD +0.04 USD (+0.20%)
Last closed 20.90 USD
ISIN US6901451079
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 370 396 064 USD
Yield for 12 month -62.02 %
1Y
3Y
5Y
10Y
15Y
OM
21.11.2021 - 28.11.2021

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Address: 3052 Orchard Drive, San Jose, CA, United States, 95134

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

26.50 USD

P/E Ratio

Dividend Yield

Financials OM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+113 689 000 USD

Last Year

+130 376 000 USD

Current Quarter

+29 752 000 USD

Last Quarter

+29 467 000 USD

Current Year

+38 564 000 USD

Last Year

+29 000 000 USD

Current Quarter

+11 066 000 USD

Last Quarter

+10 747 000 USD
EBITDA -84 625 000 USD
Operating Margin TTM -54.86 %
Price to Earnings
Return On Assets TTM -17.41 %
PEG Ratio
Return On Equity TTM -86.53 %
Wall Street Target Price 26.50 USD
Revenue TTM 115 273 000 USD
Book Value 9.37 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 5.60 %
Dividend Yield
Gross Profit TTM 41 686 000 USD
Earnings per share -28.79 USD
Diluted Eps TTM -28.79 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -98.74 %

Stock Valuation OM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.46
Price Sales TTM 3.21
Enterprise Value EBITDA -0.24
Price Book MRQ 2.23

Technical Indicators OM

For 52 Weeks

5.85 USD 72.60 USD
50 Day MA 17.43 USD
Shares Short Prior Month 564 585
200 Day MA 13.19 USD
Short Ratio 3.54
Shares Short 1 014 324
Short Percent 5.79 %